TSC-LAM results from mutations in genes TSC1 and TSC2, where it commonly manifests in the brain (e.g., seizures), renal (e.g., angiomyolipomas), and skin (e.g., lesions) divisions [2,3,4,5]. Here, TSC1 is linked to angiomyolipoma.